Type II monocytes modulate T cell–mediated central nervous system autoimmune diseaseMartin S. Weber, Scott S. Zamvil, Thomas Prod’homme et al.|Nature Medicine|2007Cited by 448
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegenerationJae Kyu Ryu, Katerina Akassoglou, Kim M. Baeten et al.|Nature Immunology|2018Cited by 210
Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammationAndrew S. Mendiola, Katerina Akassoglou, Jae Kyu Ryu et al.|Nature Immunology|2020Cited by 202
Defining blood-induced microglia functions in neurodegeneration through multiomic profilingAndrew S. Mendiola, Katerina Akassoglou, Zhaoqi Yan et al.|Nature Immunology|2023Cited by 126
Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System AutoimmunityUlf Schulze‐Topphoff, Scott S. Zamvil|PLoS ONE|2012Cited by 97